Impact of Ranolazine on Inflammatory, Thrombogenic, Lipogenic, Biomarkers in Women With Angina and Metabolic Syndrome.
Phase of Trial: Phase IV
Latest Information Update: 07 Jun 2019
Price : $35 *
At a glance
- Drugs Ranolazine (Primary)
- Indications Angina pectoris
- Focus Therapeutic Use
- Acronyms IRMA
- 31 May 2019 Status changed from active, no longer recruiting to completed.
- 08 Jan 2019 Planned End Date changed from 1 Nov 2018 to 1 Mar 2019.
- 08 Jan 2019 Planned primary completion date changed from 1 Nov 2018 to 1 Mar 2019.